These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 8158804)
1. Consensus panel says benefits of screening women for ovarian cancer currently unproven. Marwick C JAMA; 1994 May; 271(17):1305-6. PubMed ID: 8158804 [No Abstract] [Full Text] [Related]
2. USPSTF says no screening for ovarian cancer in new guidelines. Oncology (Williston Park); 2012 Oct; 26(10):896, 928. PubMed ID: 23175994 [No Abstract] [Full Text] [Related]
3. NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer. JAMA; 1995 Feb; 273(6):491-7. PubMed ID: 7837369 [TBL] [Abstract][Full Text] [Related]
4. Epidemiology and screening of ovarian cancer. Tortolero-Luna G; Mitchell MF; Rhodes-Morris HE Obstet Gynecol Clin North Am; 1994 Mar; 21(1):1-23. PubMed ID: 8015758 [TBL] [Abstract][Full Text] [Related]
5. Assessment of the recent consensus development panel on screening women aged 40-49 for breast cancer. Monsees BS AJR Am J Roentgenol; 1997 Sep; 169(3):625-6. PubMed ID: 9275866 [No Abstract] [Full Text] [Related]
6. Characteristics relating to ovarian cancer risk: implications for prevention and detection. Whittemore AS Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S15-9. PubMed ID: 7835800 [TBL] [Abstract][Full Text] [Related]
7. Screening asymptomatic women for ovarian cancer: American College of Preventive Medicine practice policy. Ferrini R Am J Prev Med; 1997; 13(6):444-6. PubMed ID: 9415790 [No Abstract] [Full Text] [Related]
8. HDL testing should be routine part of assessments of coronary heart disease risk, says consensus panel. Clin Pharm; 1992 May; 11(5):378, 381. PubMed ID: 1582128 [No Abstract] [Full Text] [Related]
10. Cancer killer may be "silent" no more. Twombly R J Natl Cancer Inst; 2007 Sep; 99(18):1359-61. PubMed ID: 17848663 [No Abstract] [Full Text] [Related]
11. Ovarian intraepithelial neoplasia and ovarian cancer. Gershenson DM; Tortolero-Luna G; Malpica A; Baker VV; Whittaker L; Johnson E; Follen Mitchell M Obstet Gynecol Clin North Am; 1996 Jun; 23(2):475-543. PubMed ID: 8784888 [TBL] [Abstract][Full Text] [Related]
12. Panel concludes ovarian cancer screening benefit unproven. Blume E J Natl Cancer Inst; 1994 May; 86(9):663-4. PubMed ID: 8158696 [No Abstract] [Full Text] [Related]
13. Screening for ovarian cancer: what we know, what we need to know. Hensley ML; Castiel M; Robson ME Oncology (Williston Park); 2000 Nov; 14(11):1601-7; discussion 1608, 1613-6. PubMed ID: 11125943 [TBL] [Abstract][Full Text] [Related]
14. NIH consensus panel recommends a range of adjuvant therapies for women with breast cancer. J Am Coll Surg; 2001 Feb; 192(2):288. PubMed ID: 11220730 [No Abstract] [Full Text] [Related]
15. Ovarian cancer screening: a look at the evidence. Fields MM; Chevlen E Clin J Oncol Nurs; 2006 Feb; 10(1):77-81. PubMed ID: 16482731 [TBL] [Abstract][Full Text] [Related]